Drug Markets/Filgrastim

Filgrastim

4 NDCs across 1 manufacturer|0 Generic,4 Brand

Filgrastim is used to treat chemotherapy-induced febrile neutropenia and neutropenia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $7 million on Filgrastim across 2,908 claims for 1,038 beneficiaries.

Filgrastim is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $304.09 to $650.05 per MLthe most expensive product costs about 2.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

0G / 4B

Manufacturers

1

competing in market

Price Spread

$304.09 – $650.05

per ML

7d Activity

4 flat

avg +0.0% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing FILGRASTIM

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

What is Filgrastim used to treat?

Filgrastim is used to treat chemotherapy-induced febrile neutropenia and neutropenia, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Filgrastim?

In 2024, Medicare Part D spent $7 million on Filgrastim across 2,908 claims for 1,038 beneficiaries.

How many Filgrastim products are on the market?

The Filgrastim drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.

What is the price range for Filgrastim?

NADAC reference prices for Filgrastim range from $304.0908 to $650.0520 per ML — the most expensive product costs about 2.1× the cheapest.

Which manufacturers make Filgrastim?

1 manufacturer lists Filgrastim in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (4).